Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Junior Research Group HCV Replication, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Gastroenterology. 2018 Nov;155(5):1366-1371.e3. doi: 10.1053/j.gastro.2018.07.019. Epub 2018 Jul 19.
Killer-cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer (NK) cells. Binding of KIR3DS1 to its recently discovered ligand, HLA-F, activates NK cells and has been associated with resolution of hepatitis C virus (HCV) infection. We investigated the mechanisms by which KIR3DS1 contributes to the antiviral immune response. Using cell culture systems, mice with humanized livers, and primary liver tissue from HCV-infected individuals, we found that the KIR3DS1 ligand HLA-F is up-regulated on HCV-infected cells, and that interactions between KIR3DS1 and HLA-F contribute to NK cell-mediated control of HCV. Strategies to promote interaction between KIR3DS1 and HLA-F might be developed for treatment of infectious diseases and cancer.
杀伤细胞免疫球蛋白样受体(KIR)是自然杀伤(NK)细胞表达的跨膜糖蛋白。KIR3DS1 与最近发现的配体 HLA-F 的结合激活 NK 细胞,并与丙型肝炎病毒(HCV)感染的消退有关。我们研究了 KIR3DS1 促进抗病毒免疫反应的机制。使用细胞培养系统、具有人源化肝脏的小鼠和 HCV 感染个体的原代肝组织,我们发现 HCV 感染细胞上调了 KIR3DS1 的配体 HLA-F,并且 KIR3DS1 和 HLA-F 之间的相互作用有助于 NK 细胞介导的 HCV 控制。促进 KIR3DS1 和 HLA-F 相互作用的策略可能被开发用于治疗传染病和癌症。